| Year |
Citation |
Score |
| 2024 |
Barnes DR, Tyrer JP, Dennis J, Leslie G, Bolla MK, Lush M, Aeilts AM, Aittomäki K, Andrieu N, Andrulis IL, Anton-Culver H, Arason A, Arun BK, Balmaña J, Bandera EV, ... ... Pearce CL, et al. Large-scale genome-wide association study of 398,238 women unveils seven novel loci associated with high-grade serous epithelial ovarian cancer risk. Medrxiv : the Preprint Server For Health Sciences. PMID 38496424 DOI: 10.1101/2024.02.29.24303243 |
0.462 |
|
| 2023 |
Phung MT, Lee AW, McLean K, Anton-Culver H, Bandera EV, Carney ME, Chang-Claude J, Cramer DW, Doherty JA, Fortner RT, Goodman MT, Harris HR, Jensen A, Modugno F, Moysich KB, ... ... Pearce CL, et al. A framework for assessing interactions for risk stratification models: the example of ovarian cancer. Journal of the National Cancer Institute. PMID 37436712 DOI: 10.1093/jnci/djad137 |
0.413 |
|
| 2023 |
Phung MT, Pearce CL, Meza R, Jeon J. Trends of Ovarian Cancer Incidence by Histotype and Race/Ethnicity in the United States 1992-2019. Cancer Research Communications. 3: 1-8. PMID 36968229 DOI: 10.1158/2767-9764.CRC-22-0410 |
0.383 |
|
| 2023 |
Hurwitz LM, Webb PM, Jordan SJ, Doherty JA, Harris HR, Goodman MT, Shvetsov YB, Modugno F, Moysich KB, Schildkraut JM, Berchuck A, Anton-Culver H, Ziogas A, Menon U, Ramus SJ, ... ... Pearce CL, et al. Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility. Jama Network Open. 6: e230666. PMID 36826816 DOI: 10.1001/jamanetworkopen.2023.0666 |
0.483 |
|
| 2023 |
Fu Z, Brooks MM, Irvin S, Jordan S, Aben KKH, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Brooks-Wilson A, Chang-Claude J, Cook LS, Cramer DW, Cushing-Haugen KL, Doherty JA, ... ... Pearce CL, et al. Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis. Journal of the National Cancer Institute. PMID 36688720 DOI: 10.1093/jnci/djad011 |
0.429 |
|
| 2022 |
Salvatore M, Hu MM, Beesley LJ, Mondul AM, Pearce CL, Friese CR, Fritsche LG, Mukherjee B. COVID-19 outcomes by cancer status, site, treatment, and vaccination. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 36626383 DOI: 10.1158/1055-9965.EPI-22-0607 |
0.309 |
|
| 2022 |
Phung MT, Webb PM, DeFazio A, Fereday S, Lee AW, Bowtell DDL, Fasching PA, Goode EL, Goodman MT, Karlan BY, Lester J, Matsuo K, Modugno F, Brenton JD, Van Gorp T, ... ... Pearce CL, et al. Lifestyle and personal factors associated with having macroscopic residual disease after ovarian cancer primary cytoreductive surgery. Gynecologic Oncology. 168: 68-75. PMID 36401943 DOI: 10.1016/j.ygyno.2022.10.018 |
0.326 |
|
| 2022 |
DeVries AA, Dennis J, Tyrer JP, Peng PC, Coetzee SG, Reyes AL, Plummer JT, Davis BD, Chen SS, Dezem FS, Aben KKH, Anton-Culver H, Antonenkova NN, Beckmann MW, Beeghly-Fadiel A, ... ... Pearce CL, et al. Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci. Journal of the National Cancer Institute. PMID 36210504 DOI: 10.1093/jnci/djac160 |
0.436 |
|
| 2022 |
Phung MT, Muthukumar A, Trabert B, Webb PM, Jordan SJ, Terry KL, Cramer DW, Titus LJ, Risch HA, Doherty JA, Harris HR, Goodman MT, Modugno F, Moysich KB, Jensen A, ... ... Pearce CL, et al. Effects of risk factors for ovarian cancer in women with and without endometriosis. Fertility and Sterility. PMID 36182623 DOI: 10.1016/j.fertnstert.2022.07.019 |
0.45 |
|
| 2022 |
Hurwitz LM, Townsend MK, Jordan SJ, Patel AV, Teras LR, Lacey JV, Doherty JA, Harris HR, Goodman MT, Shvetsov YB, Modugno F, Moysich KB, Robien K, Prizment A, Schildkraut JM, ... ... Pearce CL, et al. Modification of the Association Between Frequent Aspirin Use and Ovarian Cancer Risk: A Meta-Analysis Using Individual-Level Data From Two Ovarian Cancer Consortia. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2101900. PMID 35867953 DOI: 10.1200/JCO.21.01900 |
0.485 |
|
| 2022 |
Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaña J, ... ... Pearce CL, et al. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg. PMID 35314806 DOI: 10.1038/s41431-022-01085-y |
0.371 |
|
| 2022 |
Hanley GE, Pearce CL, Talhouk A, Kwon JS, Finlayson SJ, McAlpine JN, Huntsman DG, Miller D. Outcomes From Opportunistic Salpingectomy for Ovarian Cancer Prevention. Jama Network Open. 5: e2147343. PMID 35138400 DOI: 10.1001/jamanetworkopen.2021.47343 |
0.404 |
|
| 2022 |
Phung MT, Alimujiang A, Berchuck A, Anton-Cluver H, Schildkraut JM, Bandera EV, Chang-Claude J, Chase A, Doherty JA, Grout B, Goodman MT, Hanley GE, Lee AW, McKinnon Deurloo C, Menon U, ... ... Pearce CL, et al. Reproductive factors do not influence survival with ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 35064059 DOI: 10.1158/1055-9965.EPI-21-1091 |
0.436 |
|
| 2022 |
Dareng EO, Tyrer JP, Barnes DR, Jones MR, Yang X, Aben KKH, Adank MA, Agata S, Andrulis IL, Anton-Culver H, Antonenkova NN, Aravantinos G, Arun BK, Augustinsson A, Balmaña J, ... ... Pearce CL, et al. Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics : Ejhg. PMID 35027648 DOI: 10.1038/s41431-021-00987-7 |
0.433 |
|
| 2021 |
Brieger KK, Phung MT, Mukherjee B, Bakulski KM, Anton-Culver H, Bandera EV, Bowtell DDL, Cramer DW, DeFazio A, Doherty JA, Fereday S, Fortner RT, Gentry-Maharaj A, Goode EL, Goodman MT, ... ... Pearce CL, et al. High pre-diagnosis inflammation-related risk score associated with decreased ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 34789471 DOI: 10.1158/1055-9965.EPI-21-0977 |
0.397 |
|
| 2021 |
Khoja L, Weber RP, Webb PM, Jordan SJ, Muthukumar A, Chang-Claude J, Fortner RT, Jensen A, Kjaer SK, Risch H, Doherty JA, Harris HR, Goodman MT, Modugno F, ... ... Pearce CL, et al. Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association. Gynecologic Oncology. PMID 34776242 DOI: 10.1016/j.ygyno.2021.10.088 |
0.35 |
|
| 2021 |
Zick SM, Kruger G, Harte S, Sen A, Harris RE, Pearce CL. Acupressure for cancer-fatigue in ovarian cancer survivor (The AcuOva Study): A community-based clinical trial study protocol examining the impact of self-acupressure on persistent cancer related fatigue in ovarian cancer survivors. Contemporary Clinical Trials. 107: 106477. PMID 34119716 DOI: 10.1016/j.cct.2021.106477 |
0.308 |
|
| 2021 |
Phung MT, Lee AW, Wu AH, Berchuck A, Cho KR, Cramer DW, Doherty JA, Goodman MT, Hanley GE, Harris HR, McLean K, Modugno F, Moysich KB, Mukherjee B, Schildkraut JM, ... ... Pearce CL, et al. Depot-medroxyprogesterone acetate use is associated with decreased risk of ovarian cancer: the mounting evidence of a protective role of progestins. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33619020 DOI: 10.1158/1055-9965.EPI-20-1355 |
0.496 |
|
| 2020 |
Glubb DM, Thompson DJ, Aben KK, Alsulimani A, Amant F, Annibali D, Attia J, Barricarte A, Beckmann MW, Berchuck A, Bermisheva M, Bernardini MQ, Bischof K, Bjørge L, Bodelon C, ... ... Pearce CL, et al. Cross-cancer genome-wide association study of endometrial cancer and epithelial ovarian cancer identifies genetic risk regions associated with risk of both cancers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 33144283 DOI: 10.1158/1055-9965.EPI-20-0739 |
0.486 |
|
| 2020 |
Modugno F, Fu Z, Jordan SJ, Group A, Chang-Claude J, Fortner RT, Goodman MT, Moysich KB, Schildkraut JM, Berchuck A, Bandera EV, Qin B, Sutphen R, McLaughlin JR, Menon U, ... ... Pearce CL, et al. Offspring sex and risk of epithelial ovarian cancer: a multinational pooled analysis of 12 case-control studies. European Journal of Epidemiology. PMID 32959149 DOI: 10.1007/S10654-020-00682-9 |
0.465 |
|
| 2020 |
Lee AW, Rosenzweig S, Wiensch A, Ramus SJ, Menon U, Gentry-Maharaj A, Ziogas A, Anton-Culver H, Whittemore AS, Sieh W, Rothstein JH, McGuire V, Wentzensen N, Bandera EV, ... ... Pearce CL, et al. Expanding our understanding of ovarian cancer risk: the role of incomplete pregnancies. Journal of the National Cancer Institute. PMID 32766851 DOI: 10.1093/Jnci/Djaa099 |
0.55 |
|
| 2020 |
Brieger KK, Peterson S, Lee AW, Mukherjee B, Bakulski KM, Alimujiang A, Anton-Culver H, Anglesio MS, Bandera EV, Berchuck A, Bowtell DDL, Chenevix-Trench G, Cho KR, Cramer DW, DeFazio A, ... ... Pearce CL, et al. Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival. Gynecologic Oncology. PMID 32641237 DOI: 10.1016/J.Ygyno.2020.06.481 |
0.442 |
|
| 2020 |
Zhang YD, Hurson AN, Zhang H, Choudhury PP, Easton DF, Milne RL, Simard J, Hall P, Michailidou K, Dennis J, Schmidt MK, Chang-Claude J, Gharahkhani P, Whiteman D, Campbell PT, ... ... Pearce CL, et al. Assessment of polygenic architecture and risk prediction based on common variants across fourteen cancers. Nature Communications. 11: 3353. PMID 32620889 DOI: 10.1038/S41467-020-16483-3 |
0.542 |
|
| 2020 |
Talhouk A, George J, Wang C, Budden T, Tan TZ, Chiu DS, Kommoss S, Leong HS, Chen S, Intermaggio MP, Gilks B, Nazeran TM, Volchek M, Elatre W, Bentley RC, ... ... Pearce CL, et al. Development and validation of the gene-expression Predictor of high-grade-serous Ovarian carcinoma molecular subTYPE (PrOTYPE). Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32554541 DOI: 10.1158/1078-0432.Ccr-20-0103 |
0.361 |
|
| 2020 |
Song H, Dicks EM, Tyrer J, Intermaggio M, Chenevix-Trench G, Bowtell DD, Traficante N, Group A, Brenton J, Goranova T, Hosking K, Piskorz A, van Oudenhove E, Doherty J, Harris HR, ... ... Pearce CL, et al. Population-based targeted sequencing of 54 candidate genes identifies as a susceptibility gene for high-grade serous ovarian cancer. Journal of Medical Genetics. PMID 32546565 DOI: 10.1136/Jmedgenet-2019-106739 |
0.522 |
|
| 2020 |
Millstein J, Budden T, Goode EL, Anglesio MS, Talhouk A, Intermaggio MP, Leong HS, Chen S, Elatre W, Gilks B, Nazeran T, Volchek M, Bentley RC, Wang C, Chiu DS, ... ... Pearce CL, et al. Prognostic gene expression signature for high-grade serous ovarian cancer. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 32473302 DOI: 10.1016/J.Annonc.2020.05.019 |
0.427 |
|
| 2020 |
Babic A, Sasamoto N, Rosner BA, Tworoger SS, Jordan SJ, Risch HA, Harris HR, Rossing MA, Doherty JA, Fortner RT, Chang-Claude J, Goodman MT, Thompson PJ, Moysich KB, Ness RB, ... ... Pearce CL, et al. Association Between Breastfeeding and Ovarian Cancer Risk. Jama Oncology. e200421. PMID 32239218 DOI: 10.1001/Jamaoncol.2020.0421 |
0.549 |
|
| 2020 |
Lee AW, Wu AH, Wiensch A, Mukherjee B, Terry KL, Harris HR, Carney ME, Jensen A, Cramer DW, Berchuck A, Doherty JA, Modugno F, Goodman MT, Alimujiang A, Rossing MA, ... ... Pearce CL, et al. Estrogen plus progestin hormone therapy and ovarian cancer: a complicated relationship explored. Epidemiology (Cambridge, Mass.). PMID 32028322 DOI: 10.1097/Ede.0000000000001175 |
0.465 |
|
| 2020 |
Garsed D, Pandey A, Fereday S, Alsop K, Wouters M, Saner F, Kennedy C, Pearce C, Pike M, Ramus S, Kobel M, deFazio A, Goode E, Nelson B, Bowtell D. Abstract IA05: Molecular analysis of exceptional response in high-grade serous ovarian cancer Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Ovca19-Ia05 |
0.399 |
|
| 2020 |
Phung MT, Webb PM, Doherty JA, Harris HR, Thompson PJ, Goodman MT, Moysich K, Modugno F, Ness RB, Schildkraut JM, Berchuck A, Cramer DW, Terry KL, Titus L, Lee AW, ... ... Pearce CL, et al. Abstract B38: Use of progestin-only injectable contraceptive is associated with reduced risk of ovarian cancer in the Ovarian Cancer Association Consortium Clinical Cancer Research. 26. DOI: 10.1158/1557-3265.Ovca19-B38 |
0.565 |
|
| 2020 |
Phung MT, Mukherjee B, Lee AW, Webb PM, Risch HA, Doherty JA, Harris HR, Goodman MT, Ness RB, Modugno F, Jensen A, Kjaer SK, Terry KL, Cramer DW, Ziogas A, ... ... Pearce CL, et al. Abstract 3498: Ovarian cancer risk factors multiply to create high risk in pre-menopausal women Epidemiology. DOI: 10.1158/1538-7445.Am2020-3498 |
0.478 |
|
| 2020 |
Fazio Ad, Garsed DW, Pandey A, Fereday S, Alsop K, Wouters MCA, Gibson-Wright B, Saner F, Beach JA, Milne K, Kennedy CJ, Hendley J, Traficante N, Ramus SJ, Köbel M, ... ... Pearce CL, et al. The MOCOG study: Learning from extraordinary responders to improve treatment outcomes for women with ovarian cancer Pathology. 52. DOI: 10.1016/J.Pathol.2020.01.126 |
0.378 |
|
| 2019 |
Alimujiang A, Khoja L, Wiensch A, Pike MC, Webb PM, Chenevix-Trench G, Chase A, Richardson J, Pearce CL. "I am not a statistic" ovarian cancer survivors' views of factors that influenced their long-term survival. Gynecologic Oncology. PMID 31706666 DOI: 10.1016/J.Ygyno.2019.10.007 |
0.468 |
|
| 2019 |
Manichaikul A, Peres LC, Wang XQ, Barnard ME, Chyn D, Sheng X, Du Z, Tyrer J, Dennis J, Schwartz AG, Cote ML, Peters E, Moorman PG, Bondy M, Barnholtz-Sloan JS, ... ... Pearce CL, et al. Identification of novel epithelial ovarian cancer loci in Women of African Ancestry. International Journal of Cancer. PMID 31469419 DOI: 10.1002/Ijc.32653 |
0.493 |
|
| 2019 |
Harris HR, Cushing-Haugen KL, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjær SK, Høgdall E, ... ... Pearce CL, et al. Association between genetically predicted polycystic ovary syndrome and ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 31211375 DOI: 10.1093/Ije/Dyz113 |
0.515 |
|
| 2019 |
Saner FAM, Herschtal A, Nelson BH, deFazio A, Goode EL, Ramus SJ, Pandey A, Beach JA, Fereday S, Berchuck A, Lheureux S, Pearce CL, Pharoah PD, Pike MC, Garsed DW, et al. Going to extremes: determinants of extraordinary response and survival in patients with cancer. Nature Reviews. Cancer. PMID 31076661 DOI: 10.1038/S41568-019-0145-5 |
0.307 |
|
| 2019 |
Grant DJ, Manichaikul A, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy M, Cote ML, Funkhouser E, Moorman PG, Peres LC, Peters ES, Schwartz AG, Terry PD, Wang XQ, Keku TO, ... ... Pearce CL, et al. Evaluation of vitamin D biosynthesis and pathway target genes reveals UGT2A1/2 and EGFR polymorphisms associated with epithelial ovarian cancer in African American Women. Cancer Medicine. PMID 31001917 DOI: 10.1002/Cam4.1996 |
0.451 |
|
| 2019 |
Clarke CL, Kushi LH, Chubak J, Pawloski PA, Bulkley JE, Epstein MM, Burnett-Hartman AN, Powell B, Pearce CL, Spencer Feigelson H. Predictors of Long-Term Survival among High-Grade Serous Ovarian Cancer Patients. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 30967418 DOI: 10.1158/1055-9965.Epi-18-1324 |
0.441 |
|
| 2019 |
Minlikeeva AN, Cannioto R, Jensen A, Kjaer SK, Jordan SJ, Diergaarde B, Szender JB, Odunsi K, Almohanna H, Mayor P, Starbuck K, Zsiros E, Bandera EV, Cramer DW, Doherty JA, ... ... Pearce CL, et al. Joint exposure to smoking, excessive weight, and physical inactivity and survival of ovarian cancer patients, evidence from the Ovarian Cancer Association Consortium. Cancer Causes & Control : Ccc. PMID 30905014 DOI: 10.1007/S10552-019-01157-3 |
0.463 |
|
| 2019 |
Lawrenson K, Song F, Hazelett DJ, Kar SP, Tyrer J, Phelan CM, Corona RI, Rodríguez-Malavé NI, Seo JH, Adler E, Coetzee SG, Segato F, Fonseca MAS, Amos CI, Carney ME, ... ... Pearce CL, et al. Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women. Gynecologic Oncology. PMID 30898391 DOI: 10.1016/J.Ygyno.2019.02.023 |
0.517 |
|
| 2019 |
Lee AW, Peterson S, Wiensch A, Pike MC, Pearce CL. Abstract DP-011: PRE-DIAGNOSIS USE OF MENOPAUSAL HORMONE THERAPY ASSOCIATED WITH BETTER OVARIAN CANCER SURVIVAL Clinical Cancer Research. 25. DOI: 10.1158/1557-3265.Ovcasymp18-Dp-011 |
0.461 |
|
| 2019 |
Sasamoto N, Babic A, Jordan S, Risch H, Harris H, Rossing MA, Doherty J, Goodman M, Thompson P, Kjær SK, Jensen A, Schildkraut J, Titus L, Cramer D, Bandera E, ... ... Pearce CL, et al. Abstract 640: Breastfeeding pattern and ovarian cancer risk: Results from the Ovarian Cancer Association Consortium Epidemiology. DOI: 10.1158/1538-7445.Sabcs18-640 |
0.551 |
|
| 2019 |
Alimujiang A, Khoja L, Wiensch A, Pike MC, Webb P, Chase A, Richardson J, Pearce CL. Abstract 3288: Ovarian cancer survivors' views of factors that influenced their exceptional survival: A qualitative study Cancer Research. 79: 3288-3288. DOI: 10.1158/1538-7445.Am2019-3288 |
0.419 |
|
| 2019 |
Garsed DW, Pandey A, Fereday S, Alsop K, Wouters MC, Saner F, Beach JA, Milne K, Kennedy CJ, Hendley J, Traficante N, Pearce CL, Pike MC, Ramus SJ, Köbel M, et al. Abstract 2722: The genomic landscape of high-grade serous ovarian cancer in long-term survivors Cancer Research. 79: 2722-2722. DOI: 10.1158/1538-7445.Am2019-2722 |
0.396 |
|
| 2018 |
Yang Y, Wu L, Shu X, Lu Y, Shu XO, Cai Q, Beeghly-Fadiel A, Li B, Ye F, Berchuck A, Anton-Culver H, Banerjee S, Benitez J, Bjørge L, Brenton JD, ... ... Pearce CL, et al. Genetic data from nearly 63,000 women of European descent predicts DNA methylation biomarkers and epithelial ovarian cancer risk. Cancer Research. PMID 30559148 DOI: 10.1158/0008-5472.Can-18-2726 |
0.434 |
|
| 2018 |
Kim S, Wang M, Tyrer JP, Jensen A, Wiensch A, Liu G, Lee AW, Ness RB, Salvatore M, Tworoger SS, Whittemore AS, Anton-Culver H, Sieh W, Olson SH, Berchuck A, ... ... Pearce CL, et al. A Comprehensive Gene-Environment Interaction Analysis in Ovarian Cancer using Genome-wide Significant Common Variants. International Journal of Cancer. PMID 30499236 DOI: 10.1002/Ijc.32029 |
0.529 |
|
| 2018 |
Kelemen LE, Earp M, Fridley BL, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, Hein A, Lambrechts D, Lambrechts S, Van Nieuwenhuysen E, Vergote I, Rossing MA, Doherty JA, ... ... Pearce CL, et al. rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology. International Journal of Molecular Sciences. 19. PMID 30134598 DOI: 10.3390/Ijms19092473 |
0.425 |
|
| 2018 |
Earp M, Tyrer JP, Winham SJ, Lin HY, Chornokur G, Dennis J, Aben KKH, Anton-Culver H, Antonenkova N, Bandera EV, Bean YT, Beckmann MW, Bjorge L, Bogdanova N, Brinton LA, ... ... Pearce CL, et al. Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility. Plos One. 13: e0197561. PMID 29979793 DOI: 10.1371/Journal.Pone.0197561 |
0.526 |
|
| 2018 |
Peres LC, Risch H, Terry KL, M Webb P, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, ... ... Pearce CL, et al. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. International Journal of Epidemiology. PMID 29584862 DOI: 10.1093/Ije/Dyy054 |
0.476 |
|
| 2018 |
Dixon-Suen SC, Nagle CM, Thrift AP, Pharoah PDP, Ewing A, Pearce CL, Zheng W, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, et al. Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study. British Journal of Cancer. PMID 29555990 DOI: 10.1038/S41416-018-0011-3 |
0.542 |
|
| 2017 |
Ugai T, Kelemen LE, Mizuno M, Ong JS, Webb PM, Chenevix-Trench G, Wicklund KG, Doherty JA, Rossing MA, Thompson PJ, Wilkens LR, Carney ME, Goodman MT, Schildkraut JM, ... ... Pearce CL, et al. Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium. Cancer Science. PMID 29247577 DOI: 10.1111/Cas.13470 |
0.456 |
|
| 2017 |
Peres LC, Risch H, Terry KL, Webb PM, Goodman MT, Wu AH, Alberg AJ, Bandera EV, Barnholtz-Sloan J, Bondy ML, Cote ML, Funkhouser E, Moorman PG, Peters ES, Schwartz AG, ... ... Pearce CL, et al. Racial/ethnic differences in the epidemiology of ovarian cancer: a pooled analysis of 12 case-control studies. International Journal of Epidemiology. PMID 29211900 DOI: 10.1093/ije/dyx252 |
0.416 |
|
| 2017 |
Harris HR, Babic A, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, Modugno F, Ness RB, Moysich KB, Kjaer SK, Høgdall E, Jensen A, ... ... Pearce CL, et al. Polycystic ovary syndrome, oligomenorrhea, and risk of ovarian cancer histotypes: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29141849 DOI: 10.1158/1055-9965.Epi-17-0655 |
0.557 |
|
| 2017 |
Doherty JA, Jensen A, Kelemen LE, Pearce CL, Poole E, Schildkraut JM, Terry KL, Tworoger SS, Webb PM, Wentzensen N. Current Gaps in Ovarian Cancer Epidemiology: The Need for New Population-Based Research. Journal of the National Cancer Institute. 109. PMID 29117355 DOI: 10.1093/Jnci/Djx144 |
0.485 |
|
| 2017 |
Minlikeeva AN, Freudenheim JL, Eng KH, Cannioto RA, Friel G, Szender JB, Segal B, Odunsi K, Mayor P, Diergaarde B, Zsiros E, Kelemen LE, Köbel M, Steed H, deFazio A, ... ... Pearce CL, et al. History of Comorbidities and Survival of Ovarian Cancer Patients, Results from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 26: 1470-1473. PMID 28864456 DOI: 10.1158/1055-9965.Epi-17-0367 |
0.505 |
|
| 2017 |
Babic A, Harris HR, Vitonis AF, Titus LJ, Jordan SJ, Webb PM, Risch HA, Rossing MA, Doherty JA, Wicklund K, Goodman MT, Modugno F, Moysich KB, Ness R, ... ... Pearce CL, et al. Menstrual pain and risk of epithelial ovarian cancer: results from the Ovarian Cancer Association Consortium. International Journal of Cancer. PMID 28833087 DOI: 10.1002/Ijc.31010 |
0.45 |
|
| 2017 |
Wu AH, Pearce CL, Lee A, Tseng C, Jotwani A, Patel P, Pike MC. Timing of births and oral contraceptive use influences ovarian cancer risk. International Journal of Cancer. PMID 28748634 DOI: 10.1002/Ijc.30910 |
0.44 |
|
| 2017 |
Kar SP, Berchuck A, Gayther SA, Goode EL, Moysich KB, Pearce CL, Ramus SJ, Schildkraut JM, Sellers TA, Pharoah PDP. Common Genetic Variation and Susceptibility to Ovarian Cancer: Current Insights and Future Directions. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28615364 DOI: 10.1158/1055-9965.Epi-17-0315 |
0.517 |
|
| 2017 |
Dixon SC, Nagle CM, Wentzensen N, Trabert B, Beeghly-Fadiel A, Schildkraut JM, Moysich KB, deFazio A, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, ... ... Pearce CL, et al. Use of common analgesic medications and ovarian cancer survival: results from a pooled analysis in the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 28350790 DOI: 10.1038/Bjc.2017.68 |
0.499 |
|
| 2017 |
Kar SP, Adler E, Tyrer J, Hazelett D, Anton-Culver H, Bandera EV, Beckmann MW, Berchuck A, Bogdanova N, Brinton L, Butzow R, Campbell I, Carty K, Chang-Claude J, Cook LS, ... ... Pearce CL, et al. Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci. British Journal of Cancer. PMID 28103614 DOI: 10.1038/Bjc.2016.426 |
0.545 |
|
| 2017 |
Brüggmann D, Pulch K, Klingelhöfer D, Pearce CL, Groneberg DA. Ovarian cancer: density equalizing mapping of the global research architecture. International Journal of Health Geographics. 16: 3. PMID 28086974 DOI: 10.1186/S12942-016-0076-2 |
0.442 |
|
| 2017 |
Praestegaard C, Jensen A, Jensen SM, Nielsen TS, Webb PM, Nagle CM, DeFazio A, Høgdall E, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, ... ... Pearce CL, et al. Cigarette smoking is associated with adverse survival among women with ovarian cancer: results from a pooled analysis of 19 studies. International Journal of Cancer. PMID 28063166 DOI: 10.1002/Ijc.30600 |
0.421 |
|
| 2017 |
Bodelon C, Risch H, Modugno F, Webb P, Pearce CL, Pike M, Wentzensen N. Abstract A27: Timing of pregnancies and oral contraceptive use and risk of ovarian cancer Cancer Epidemiology and Prevention Biomarkers. 26. DOI: 10.1158/1538-7755.Carisk16-A27 |
0.529 |
|
| 2017 |
Mullins M, Mukherjee B, Wu AH, Pike M, Pharoah PD, Berchuck A, Pearce CL. Explaining Disparities in Ovarian Cancer Incidence Rates between Women of African and European Ancestry: The Role of Genetic Factors. Cancer Epidemiology, Biomarkers & Prevention. 26: 433-434. DOI: 10.1158/1055-9965.Epi-17-0030 |
0.535 |
|
| 2017 |
Berchuck A, Tyrer J, Kelemen L, Phelan C, Pearce C, Moysich K, Lawrenson K, Schildkraut J, Sellers T, Goode E, Gayther S, Pharoah P. Genome-wide significant associations of common low penetrance single nucleotide polymorphisms with risk of mucinous ovarian carcinoma Gynecologic Oncology. 145: 41-42. DOI: 10.1016/J.Ygyno.2017.03.107 |
0.435 |
|
| 2016 |
Reid BM, Permuth JB, Chen YA, Teer JK, Monteiro AN, Chen Z, Tyrer J, Berchuck A, Chenevix-Trench G, Doherty JA, Goode EL, Iverson ES, Lawrenson K, ... Pearce CL, et al. Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 28035019 DOI: 10.1158/1055-9965.EPI-16-0341 |
0.383 |
|
| 2016 |
Rasmussen CB, Kjaer SK, Albieri V, Bandera EV, Doherty JA, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Wicklund KG, Goodman MT, Modugno F, Moysich KB, Ness RB, Edwards RP, ... ... Pearce CL, et al. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies. American Journal of Epidemiology. PMID 27941069 DOI: 10.1093/Aje/Kww161 |
0.53 |
|
| 2016 |
Permuth JB, Reid B, Earp M, Chen YA, Monteiro AN, Chen Z, Aocs Study Group, Chenevix-Trench G, Fasching PA, Beckmann MW, Lambrechts D, Vanderstichele A, Van Niewenhuyse E, Vergote I, Rossing MA, ... ... Pearce CL, et al. Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration. Oncotarget. 7: 72381-72394. PMID 27911851 DOI: 10.18632/Oncotarget.10546 |
0.45 |
|
| 2016 |
Karnezis AN, Cho KR, Gilks CB, Pearce CL, Huntsman DG. The disparate origins of ovarian cancers: pathogenesis and prevention strategies. Nature Reviews. Cancer. PMID 27885265 DOI: 10.1038/Nrc.2016.113 |
0.515 |
|
| 2016 |
Hanley GE, McAlpine JN, Pearce CL, Miller D. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States. American Journal of Obstetrics and Gynecology. PMID 27810554 DOI: 10.1016/J.Ajog.2016.10.035 |
0.457 |
|
| 2016 |
Clyde MA, Palmieri Weber R, Iversen ES, Poole EM, Doherty JA, Goodman MT, Ness RB, Risch HA, Rossing MA, Terry KL, Wentzensen N, Whittemore AS, Anton-Culver H, Bandera EV, Berchuck A, ... ... Pearce CL, et al. Risk Prediction for Epithelial Ovarian Cancer in 11 United States-Based Case-Control Studies: Incorporation of Epidemiologic Risk Factors and 17 Confirmed Genetic Loci. American Journal of Epidemiology. PMID 27698005 DOI: 10.1093/Aje/Kww091 |
0.35 |
|
| 2016 |
Sucheston-Campbell LE, Cannioto R, Clay AI, Etter JL, Eng KH, Liu S, Battaglia S, Hu Q, Szender JB, Minlikeeva A, Joseph J, Mayor P, Abrams SI, Segal B, Wallace PK, ... ... Pearce CL, et al. No evidence that genetic variation in the myeloid-derived suppressor cell pathway influences ovarian cancer survival. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27677730 DOI: 10.1158/1055-9965.Epi-16-0631 |
0.466 |
|
| 2016 |
Lawrenson K, Kar S, McCue K, Kuchenbaeker K, Michailidou K, Tyrer J, Beesley J, Ramus SJ, Li Q, Delgado MK, Lee JM, Aittomäki K, Andrulis IL, Anton-Culver H, Arndt V, ... ... Pearce CL, et al. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus. Nature Communications. 7: 12675. PMID 27601076 DOI: 10.1038/ncomms12675 |
0.398 |
|
| 2016 |
Southey MC, Goldgar DE, Winqvist R, Pylkäs K, Couch F, Tischkowitz M, Foulkes WD, Dennis J, Michailidou K, van Rensburg EJ, Heikkinen T, Nevanlinna H, Hopper JL, Dörk T, Claes KB, ... ... Pearce CL, et al. PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS. Journal of Medical Genetics. PMID 27595995 DOI: 10.1136/jmedgenet-2016-103839 |
0.37 |
|
| 2016 |
Ong JS, Cuellar-Partida G, Lu Y, Ovarian Cancer Study A, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Anne Doherty J, Anne Rossing M, Chang-Claude J, ... ... Pearce CL, et al. Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. International Journal of Epidemiology. PMID 27594614 DOI: 10.1093/Ije/Dyw207 |
0.457 |
|
| 2016 |
Hampras SS, Sucheston-Campbell LE, Cannioto R, Chang-Claude J, Modugno F, Dörk T, Hillemanns P, Preus L, Knutson KL, Wallace PK, Hong CC, Friel G, Davis W, Nesline M, Pearce CL, et al. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer. Oncotarget. PMID 27533245 DOI: 10.18632/Oncotarget.10215 |
0.471 |
|
| 2016 |
Kar SP, Beesley J, Amin Al Olama A, Michailidou K, Tyrer J, Kote-Jarai Z, Lawrenson K, Lindstrom S, Ramus SJ, Thompson DJ, Kibel AS, Dansonka-Mieszkowska A, Michael A, Dieffenbach AK, ... ... Pearce CL, et al. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. Cancer Discovery. PMID 27432226 DOI: 10.1158/2159-8290.Cd-15-1227 |
0.55 |
|
| 2016 |
Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, ... ... Pearce CL, et al. A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer. International Journal of Cancer. PMID 27420401 DOI: 10.1002/Ijc.30274 |
0.548 |
|
| 2016 |
Dixon SC, Nagle CM, Thrift AP, Pharoah PD, Pearce CL, Zheng W, Painter JN, Chenevix-Trench AG, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Lambrechts S, Van Nieuwenhuysen E, Rossing MA, et al. Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. International Journal of Epidemiology. PMID 27401727 DOI: 10.1093/Ije/Dyw158 |
0.535 |
|
| 2016 |
Permuth JB, Pirie A, Chen YA, Lin HY, Reid BM, Chen Z, Monteiro A, Dennis J, Mendoza-Fandino G, Anton-Culver H, Bandera EV, Bisogna M, Brinton L, ... ... Pearce CL, et al. Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. Human Molecular Genetics. PMID 27378695 DOI: 10.1093/Hmg/Ddw196 |
0.48 |
|
| 2016 |
Cannioto RA, LaMonte MJ, Kelemen LE, Risch HA, Eng KH, Minlikeeva AN, Hong CC, Szender JB, Sucheston-Campbell L, Joseph JM, Berchuck A, Chang-Claude J, Cramer DW, DeFazio A, Diergaarde B, ... ... Pearce CL, et al. Recreational physical inactivity and mortality in women with invasive epithelial ovarian cancer: evidence from the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 27299959 DOI: 10.1038/Bjc.2016.153 |
0.523 |
|
| 2016 |
Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli GR, Bandera EV, Berchuck A, ... ... Pearce CL, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 27197285 DOI: 10.1158/1055-9965.Epi-15-1330 |
0.53 |
|
| 2016 |
Cuellar-Partida G, Lu Y, Dixon SC, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, Doherty JA, Rossing MA, Chang-Claude J, ... ... Pearce CL, et al. Assessing the genetic architecture of epithelial ovarian cancer histological subtypes. Human Genetics. PMID 27075448 DOI: 10.1007/S00439-016-1663-9 |
0.423 |
|
| 2016 |
Lee AW, Ness RB, Roman LD, Terry KL, Schildkraut JM, Chang-Claude J, Doherty JA, Menon U, Cramer DW, Gayther SA, Risch H, Gentry-Maharaj A, Goodman MT, Modugno F, Eilber U, ... ... Pearce CL, et al. Association Between Menopausal Estrogen-Only Therapy and Ovarian Carcinoma Risk. Obstetrics and Gynecology. PMID 27054934 DOI: 10.1097/01.Ogx.0000489579.62561.B8 |
0.379 |
|
| 2016 |
Usset JL, Raghavan R, Tyrer JP, McGuire V, Sieh W, Webb P, Chang-Claude J, Rudolph A, Anton-Culver H, Berchuck A, Brinton LA, Cunningham JM, deFazio A, Doherty JA, Edwards RP, ... ... Pearce CL, et al. Assessment of multifactor gene-environment interactions and ovarian cancer risk: candidate genes, obesity, and hormone-related risk factors. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26976855 DOI: 10.1158/1055-9965.Epi-15-1039 |
0.414 |
|
| 2016 |
Præstegaard C, Kjaer SK, Nielsen TS, Jensen SM, Webb PM, Nagle CM, Høgdall E, Risch HA, Rossing MA, Doherty JA, Wicklund KG, Goodman MT, Modugno F, Moysich K, Ness RB, ... ... Pearce CL, et al. The association between socioeconomic status and tumour stage at diagnosis of ovarian cancer: A pooled analysis of 18 case-control studies. Cancer Epidemiology. 41: 71-79. PMID 26851750 DOI: 10.1016/J.Canep.2016.01.012 |
0.449 |
|
| 2016 |
Earp M, Winham SJ, Larson N, Permuth JB, Sicotte H, Chien J, Anton-Culver H, Bandera EV, Berchuck A, Cook LS, Cramer D, Doherty JA, Goodman MT, Levine DA, Monteiro AN, ... ... Pearce CL, et al. A targeted genetic association study of epithelial ovarian cancer susceptibility. Oncotarget. 7: 7381-9. PMID 26848776 DOI: 10.18632/Oncotarget.7121 |
0.539 |
|
| 2016 |
Winham SJ, Pirie A, Chen YA, Larson MC, Fogarty ZC, Earp MA, Anton-Culver H, Bandera EV, Cramer D, Doherty JA, Goodman MT, Gronwald J, Karlan BY, Kjaer SK, Levine DA, ... ... Pearce CL, et al. Investigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 25: 446-54. PMID 26747452 DOI: 10.1158/1055-9965.EPI-15-0240 |
0.434 |
|
| 2016 |
Lee AW, Bomkamp A, Bandera EV, Jensen A, Ramus SJ, Goodman MT, Rossing MA, Modugno F, Moysich KB, Chang-Claude J, Rudolph A, Gentry-Maharaj A, Terry KL, Gayther SA, Cramer DW, ... ... Pearce CL, et al. Abstract 797: A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer Cancer Research. 76: 797-797. DOI: 10.1158/1538-7445.Am2016-797 |
0.528 |
|
| 2016 |
Cannioto R, LaMonte MJ, Risch HA, Hong CC, Sucheston-Campbell LE, Eng KH, Szender JB, Chang-Claude J, Schmalfeldt B, Klapdor R, Gower E, Minlikeeva AN, Zirpoli G, Bandera EV, Berchuck A, ... ... Pearce CL, et al. Chronic Recreational Physical Inactivity and Epithelial Ovarian Cancer Risk: Evidence from the Ovarian Cancer Association Consortium Obstetrical and Gynecological Survey. 71: 528-530. DOI: 10.1097/Ogx.0000000000000357 |
0.497 |
|
| 2016 |
Berchuck A, Mullins M, Pharoah PDP, Pike M, Schildkraut JM, Pearce CL. Common single nucleotide polymorphisms associated with ovarian cancer risk contribute to the racial disparity in incidence Gynecologic Oncology. 141: 11. DOI: 10.1016/J.Ygyno.2016.04.057 |
0.565 |
|
| 2015 |
Jim HS, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Chen Z, Chen AY, Permuth-Wey J, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, ... ... Pearce CL, et al. Common Genetic Variation in Circadian Rhythm Genes and Risk of Epithelial Ovarian Cancer (EOC). Journal of Genetics and Genome Research. 2. PMID 26807442 |
0.502 |
|
| 2015 |
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, et al. Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 48: 101. PMID 26711112 DOI: 10.1038/Ng0116-101B |
0.384 |
|
| 2015 |
Lee AW, Templeman C, Stram DA, Beesley J, Tyrer J, Berchuck A, Pharoah PP, Chenevix-Trench G, Pearce CL. Evidence of a genetic link between endometriosis and ovarian cancer. Fertility and Sterility. PMID 26477498 DOI: 10.1016/j.fertnstert.2015.09.023 |
0.449 |
|
| 2015 |
Lawrenson K, Iversen ES, Tyrer J, Weber RP, Concannon P, Hazelett DJ, Li Q, Marks JR, Berchuck A, Lee JM, Aben KK, Anton-Culver H, Antonenkova N, ... ... Pearce CL, et al. Common Variants at the CHEK2 Gene Locus and Risk of Epithelial Ovarian Cancer. Carcinogenesis. PMID 26424751 DOI: 10.1093/carcin/bgv138 |
0.408 |
|
| 2015 |
Amankwah EK, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Chornokur G, Aben KK, Anton-Culver H, Antonenkova N, Bruinsma F, Bandera EV, Bean YT, Beckmann MW, Bisogna M, Bjorge L, ... ... Pearce CL, et al. Epithelial-Mesenchymal Transition (EMT) Gene Variants and Epithelial Ovarian Cancer (EOC) Risk. Genetic Epidemiology. PMID 26399219 DOI: 10.1002/Gepi.21921 |
0.495 |
|
| 2015 |
Lawrenson K, Li Q, Kar S, Seo JH, Tyrer J, Spindler TJ, Lee J, Chen Y, Karst A, Drapkin R, Aben KK, Anton-Culver H, Antonenkova N, Baker H, ... ... Pearce CL, et al. Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer. Nature Communications. 6: 8234. PMID 26391404 DOI: 10.1038/Ncomms9234 |
0.508 |
|
| 2015 |
Lu Y, Cuellar G, Painter JN, Nyholt D, Morris AP, Fasching PA, Hein A, Burghaus S, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Vanderstichele A, ... ... Pearce CL, et al. Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. Human Molecular Genetics. PMID 26231222 DOI: 10.1093/Hmg/Ddv306 |
0.527 |
|
| 2015 |
Kar SP, Tyrer JP, Li Q, Lawrenson K, Aben KK, Anton-Culver H, Antonenkova N, Chenevix-Trench G, Baker H, Bandera E, Bean YT, Beckmann MW, Berchuck A, Bisogna M, Bjørge L, ... ... Pearce CL, et al. Network-based integration of GWAS and gene expression identifies a HOX-centric network associated with serous ovarian cancer risk. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26209509 DOI: 10.1158/1055-9965.Epi-14-1270 |
0.506 |
|
| 2015 |
Johnatty S, Tyrer JP, Kar SP, Beesley J, Lu Y, Gao B, Fasching PA, Hein A, Ekici AB, Beckmann MW, Lambrechts D, Van Nieuwenhuysen E, Vergote I, Lambrechts S, Rossing MA, ... ... Pearce CL, et al. Genome-wide analysis identifies novel loci associated with ovarian cancer outcomes: findings from the Ovarian Cancer Association Consortium. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 26152742 DOI: 10.1158/1078-0432.Ccr-15-0632 |
0.52 |
|
| 2015 |
Nagle CM, Dixon SC, Jensen A, Kjaer SK, Modugno F, deFazio A, Fereday S, Hung J, Johnatty SE, Fasching PA, Beckmann MW, Lambrechts D, Vergote I, Van Nieuwenhuysen E, ... ... Pearce CL, et al. Obesity and survival among women with ovarian cancer: results from the Ovarian Cancer Association Consortium. British Journal of Cancer. PMID 26151456 DOI: 10.1038/Bjc.2015.245 |
0.504 |
|
| 2015 |
Chornokur G, Lin HY, Tyrer JP, Lawrenson K, Dennis J, Amankwah EK, Qu X, Tsai YY, Jim HS, Chen Z, Chen AY, Permuth-Wey J, Aben KKh, Anton-Culver H, Antonenkova N, ... ... Pearce CL, et al. Common Genetic Variation In Cellular Transport Genes and Epithelial Ovarian Cancer (EOC) Risk. Plos One. 10: e0128106. PMID 26091520 DOI: 10.1371/Journal.Pone.0128106 |
0.529 |
|
| 2015 |
Ness R, Pearce C, Stram D, Berchuck A, Pike M, Pharoah P. LIFETIME RISK OF OVARIAN CANCER BASED ON ENDOMETRIOSIS AND OTHER RISK FACTORS: IGCS-0014 06. Ovarian Cancer. International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society. 25: 50. PMID 25955930 DOI: 10.1097/00009577-201505001-00039 |
0.529 |
|
| 2015 |
Hollestelle A, van der Baan FH, Berchuck A, Johnatty SE, Aben KK, Agnarsson BA, Aittomäki K, Alducci E, Andrulis IL, Anton-Culver H, Antonenkova NN, Antoniou AC, Apicella C, Arndt V, ... ... Pearce CL, et al. No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. Gynecologic Oncology. PMID 25940428 DOI: 10.1016/J.Ygyno.2015.04.034 |
0.518 |
|
| 2015 |
Wu AH, Pearce CL, Tseng CC, Pike MC. African Americans and Hispanics Remain at Lower Risk of Ovarian Cancer Than Non-Hispanic Whites after Considering Nongenetic Risk Factors and Oophorectomy Rates. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 1094-100. PMID 25873577 DOI: 10.1158/1055-9965.Epi-15-0023 |
0.416 |
|
| 2015 |
Davis SJ, Sheppard KE, Anglesio MS, George J, Traficante N, Fereday S, Intermaggio MP, Menon U, Gentry-Maharaj A, Lubinski J, Gronwald J, Pearce CL, Pike MC, Wu A, Kommoss S, et al. Enhanced GAB2 Expression Is Associated with Improved Survival in High-Grade Serous Ovarian Cancer and Sensitivity to PI3K Inhibition. Molecular Cancer Therapeutics. 14: 1495-503. PMID 25852062 DOI: 10.1158/1535-7163.Mct-15-0039 |
0.436 |
|
| 2015 |
Pearce CL, Stram DO, Ness RB, Stram DA, Roman LD, Templeman C, Lee AW, Menon U, Fasching PA, McAlpine JN, Doherty JA, Modugno F, Schildkraut JM, Rossing MA, Huntsman DG, et al. Population distribution of lifetime risk of ovarian cancer in the United States. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 24: 671-6. PMID 25623732 DOI: 10.1158/1055-9965.Epi-14-1128 |
0.478 |
|
| 2015 |
Kuchenbaecker KB, Ramus SJ, Tyrer J, Lee A, Shen HC, Beesley J, Lawrenson K, McGuffog L, Healey S, Lee JM, Spindler TJ, Lin YG, Pejovic T, Bean Y, Li Q, ... ... Pearce CL, et al. Identification of six new susceptibility loci for invasive epithelial ovarian cancer. Nature Genetics. 47: 164-71. PMID 25581431 DOI: 10.1038/ng.3185 |
0.398 |
|
| 2015 |
Lee AW, Tyrer JP, Doherty JA, Stram DA, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Spiewankiewicz B, Myers EJ, Chenevix-Trench G, Fasching PA, Beckmann MW, Ekici AB, ... ... Pearce CL, et al. Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. Gynecologic Oncology. 136: 542-8. PMID 25528498 DOI: 10.1016/J.Ygyno.2014.12.017 |
0.484 |
|
| 2015 |
Dixon SC, Nagle CM, Thrift AP, Pharoah PDP, Pirie A, Pearce CL, Zheng W, Webb PM. Abstract 881: Association of adult body mass index and height with risk of ovarian cancer in 39,000 women: Results of a Mendelian randomization study Cancer Research. 75: 881-881. DOI: 10.1158/1538-7445.Am2015-881 |
0.575 |
|
| 2015 |
Lee A, Pearce CL, Wu A, Pike M. Abstract 868: The effects of age at term-births on risk of ovarian cancer Cancer Research. 75: 868-868. DOI: 10.1158/1538-7445.Am2015-868 |
0.522 |
|
| 2014 |
Kelemen LE, Terry KL, Goodman MT, Webb PM, Bandera EV, McGuire V, Rossing MA, Wang Q, Dicks E, Tyrer JP, Song H, Kupryjanczyk J, Dansonka-Mieszkowska A, Plisiecka-Halasa J, Timorek A, ... ... Pearce CL, et al. Consortium analysis of gene and gene-folate interactions in purine and pyrimidine metabolism pathways with ovarian carcinoma risk. Molecular Nutrition & Food Research. 58: 2023-35. PMID 25066213 DOI: 10.1002/Mnfr.201400068 |
0.354 |
|
| 2014 |
Frasco MA, Karim R, Van Den Berg D, Watanabe RM, Anastos K, Cohen M, Gange SJ, Gustafson DR, Liu C, Tien PC, Mack WJ, Pearce CL. Antiretroviral therapy modifies the genetic effect of known type 2 diabetes-associated risk variants in HIV-infected women. Aids (London, England). 28: 1815-23. PMID 24932614 DOI: 10.1097/Qad.0000000000000366 |
0.699 |
|
| 2014 |
Charbonneau B, Moysich KB, Kalli KR, Oberg AL, Vierkant RA, Fogarty ZC, Block MS, Maurer MJ, Goergen KM, Fridley BL, Cunningham JM, Rider DN, Preston C, Hartmann LC, Lawrenson K, ... ... Pearce CL, et al. Large-scale evaluation of common variation in regulatory T cell-related genes and ovarian cancer outcome. Cancer Immunology Research. 2: 332-40. PMID 24764580 DOI: 10.1158/2326-6066.Cir-13-0136 |
0.507 |
|
| 2014 |
Block MS, Charbonneau B, Vierkant RA, Fogarty Z, Bamlet WR, Pharoah PD, Rossing MA, Cramer D, Pearce CL, Schildkraut J, Menon U, Kjaer SK, et al. Variation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1421-7. PMID 24740199 DOI: 10.1158/1055-9965.Epi-13-0962 |
0.449 |
|
| 2014 |
Trabert B, Ness RB, Lo-Ciganic WH, Murphy MA, Goode EL, Poole EM, Brinton LA, Webb PM, Nagle CM, Jordan SJ, Risch HA, Rossing MA, Doherty JA, Goodman MT, ... ... Pearce CL, et al. Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. Journal of the National Cancer Institute. 106: djt431. PMID 24503200 DOI: 10.1093/Jnci/Djt431 |
0.385 |
|
| 2014 |
Charbonneau B, Block MS, Bamlet WR, Vierkant RA, Kalli KR, Fogarty Z, Rider DN, Sellers TA, Tworoger SS, Poole E, Risch HA, Salvesen HB, Kiemeney LA, Baglietto L, Giles GG, ... ... Pearce CL, et al. Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. Cancer Research. 74: 852-61. PMID 24272484 DOI: 10.1158/0008-5472.Can-13-1051 |
0.588 |
|
| 2014 |
Earp MA, Kelemen LE, Magliocco AM, Swenerton KD, Chenevix-Trench G, Lu Y, Hein A, Ekici AB, Beckmann MW, Fasching PA, Lambrechts D, Despierre E, Vergote I, ... ... Pearce CL, et al. Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA. Human Genetics. 133: 481-97. PMID 24190013 DOI: 10.1007/S00439-013-1383-3 |
0.52 |
|
| 2014 |
Kelemen LE, Tyrer J, Phelan CM, Ramus SJ, Berchuck A, Gayther SA, Goode EL, Pearce CL, Schildkraut JM, Chenevix-Trench G, Monteiro AN, Goodman MT, Sellers TA, Pharoah PP. Abstract 3283: GWAS identifies risk variants for mucinous ovarian carcinoma Cancer Research. 74: 3283-3283. DOI: 10.1158/1538-7445.Am2014-3283 |
0.448 |
|
| 2013 |
Pike MC, Pearce CL. Mammographic density, MRI background parenchymal enhancement and breast cancer risk. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. 24: viii37-viii41. PMID 24131968 DOI: 10.1093/Annonc/Mdt310 |
0.335 |
|
| 2013 |
Avdoshina V, Mocchetti I, Liu C, Young MA, Anastos K, Cohen M, Crystal H, Pearce CL, Golub ET, Tractenberg RE. Single-nucleotide polymorphisms in TrkB and risk for depression: findings from the women's interagency HIV study. Journal of Acquired Immune Deficiency Syndromes (1999). 64: 138-41. PMID 24047966 DOI: 10.1097/Qai.0B013E3182A468E9 |
0.31 |
|
| 2013 |
Sundermann EE, Bishop JR, Rubin LH, Aouizerat B, Wilson TE, Weber KM, Cohen M, Golub E, Anastos K, Liu C, Crystal H, Pearce CL, Maki PM. HIV serostatus differs by catechol-O-methyltransferase Val158Met genotype. Aids (London, England). 27: 1779-82. PMID 23807274 DOI: 10.1097/Qad.0B013E328361C6A1 |
0.3 |
|
| 2013 |
Terry KL, Karageorgi S, Shvetsov YB, Merritt MA, Lurie G, Thompson PJ, Carney ME, Weber RP, Akushevich L, Lo-Ciganic WH, Cushing-Haugen K, Sieh W, Moysich K, Doherty JA, Nagle CM, ... ... Pearce CL, et al. Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls. Cancer Prevention Research (Philadelphia, Pa.). 6: 811-21. PMID 23761272 DOI: 10.1158/1940-6207.Capr-13-0037 |
0.514 |
|
| 2013 |
Sieh W, Salvador S, McGuire V, Weber RP, Terry KL, Rossing MA, Risch H, Wu AH, Webb PM, Moysich K, Doherty JA, Felberg A, Miller D, Jordan SJ, ... ... Pearce CL, et al. Tubal ligation and risk of ovarian cancer subtypes: a pooled analysis of case-control studies. International Journal of Epidemiology. 42: 579-89. PMID 23569193 DOI: 10.1093/Ije/Dyt042 |
0.466 |
|
| 2013 |
Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE, Hillman KM, Mai PL, Lawrenson K, Stutz MD, Lu Y, ... ... Pearce CL, et al. Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nature Genetics. 45: 371-84, 384e1-2. PMID 23535731 DOI: 10.1038/Ng.2566 |
0.496 |
|
| 2013 |
Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H, Weber R, Karevan R, Larson MC, Song H, Tessier DC, ... ... Pearce CL, et al. GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nature Genetics. 45: 362-70, 370e1-2. PMID 23535730 DOI: 10.1038/Ng.2564 |
0.502 |
|
| 2013 |
Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC, Köbel M, Ziogas A, Zheng W, Yang HP, ... ... Pearce CL, et al. Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nature Communications. 4: 1628. PMID 23535649 DOI: 10.1038/Ncomms2629 |
0.574 |
|
| 2013 |
Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X, Ramus SJ, Karevan R, Lee J, Lee N, Larson MC, ... ... Pearce CL, et al. Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nature Communications. 4: 1627. PMID 23535648 DOI: 10.1038/Ncomms2613 |
0.463 |
|
| 2013 |
White KL, Vierkant RA, Fogarty ZC, Charbonneau B, Block MS, Pharoah PD, Chenevix-Trench G, Rossing MA, Cramer DW, Pearce CL, Schildkraut JM, Menon U, Kjaer SK, Levine DA, et al. Analysis of over 10,000 Cases finds no association between previously reported candidate polymorphisms and ovarian cancer outcome. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 987-92. PMID 23513043 DOI: 10.1158/1055-9965.Epi-13-0028 |
0.547 |
|
| 2013 |
Pearce CL, Rossing MA, Lee AW, Ness RB, Webb PM, Chenevix-Trench G, Jordan SM, Stram DA, Chang-Claude J, Hein R, Nickels S, Lurie G, Thompson PJ, et al. Combined and interactive effects of environmental and GWAS-identified risk factors in ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 880-90. PMID 23462924 DOI: 10.1158/1055-9965.Epi-12-1030-T |
0.499 |
|
| 2013 |
Faber MT, Kjær SK, Dehlendorff C, Chang-Claude J, Andersen KK, Høgdall E, Webb PM, Jordan SJ, Rossing MA, Doherty JA, Lurie G, Thompson PJ, Carney ME, ... ... Pearce CL, et al. Cigarette smoking and risk of ovarian cancer: a pooled analysis of 21 case-control studies. Cancer Causes & Control : Ccc. 24: 989-1004. PMID 23456270 DOI: 10.1007/S10552-013-0174-4 |
0.471 |
|
| 2013 |
Olsen CM, Nagle CM, Whiteman DC, Ness R, Pearce CL, Pike MC, Rossing MA, Terry KL, Wu AH, Risch HA, Yu H, Doherty JA, Chang-Claude J, et al. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium. Endocrine-Related Cancer. 20: 251-62. PMID 23404857 DOI: 10.1530/Erc-12-0395 |
0.559 |
|
| 2013 |
Berchuck A, Pearce C, Goode E, Schildkraut J, Gayther S, Chenevix-Trench G, Pharoah P, Sellers T. Common single nucleotide polymorphisms that increase ovarian cancer risk: Update from the Ovarian Cancer Association Consortium Gynecologic Oncology. 130. DOI: 10.1016/J.Ygyno.2013.04.464 |
0.59 |
|
| 2012 |
Frasco MA, Mack WJ, Van Den Berg D, Aouizerat BE, Anastos K, Cohen M, De Hovitz J, Golub ET, Greenblatt RM, Liu C, Conti DV, Pearce CL. Underlying genetic structure impacts the association between CYP2B6 polymorphisms and response to efavirenz and nevirapine. Aids (London, England). 26: 2097-106. PMID 22951632 DOI: 10.1097/Qad.0B013E3283593602 |
0.722 |
|
| 2012 |
Pearce CL, Templeman C, Rossing MA, Lee A, Near AM, Webb PM, Nagle CM, Doherty JA, Cushing-Haugen KL, Wicklund KG, Chang-Claude J, Hein R, Lurie G, Wilkens LR, Carney ME, et al. Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. The Lancet. Oncology. 13: 385-94. PMID 22361336 DOI: 10.1016/S1470-2045(11)70404-1 |
0.562 |
|
| 2012 |
Pearce CL, Berchuck A. Endometriosis and ovarian cancer - Authors' reply The Lancet Oncology. 13. DOI: 10.1016/S1470-2045(12)70103-1 |
0.493 |
|
| 2011 |
Campan M, Moffitt M, Houshdaran S, Shen H, Widschwendter M, Daxenbichler G, Long T, Marth C, Laird-Offringa IA, Press MF, Dubeau L, Siegmund KD, Wu AH, Groshen S, Chandavarkar U, ... ... Pearce CL, et al. Genome-scale screen for DNA methylation-based detection markers for ovarian cancer. Plos One. 6: e28141. PMID 22163280 DOI: 10.1371/Journal.Pone.0028141 |
0.379 |
|
| 2011 |
Lurie G, Wilkens LR, Thompson PJ, Shvetsov YB, Matsuno RK, Carney ME, Palmieri RT, Wu AH, Pike MC, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Ramus SJ, Whittemore AS, et al. Estrogen receptor beta rs1271572 polymorphism and invasive ovarian carcinoma risk: pooled analysis within the Ovarian Cancer Association Consortium. Plos One. 6: e20703. PMID 21673961 DOI: 10.1371/Journal.Pone.0020703 |
0.51 |
|
| 2011 |
Pearce CL, Doherty JA, Van Den Berg DJ, Moysich K, Hsu C, Cushing-Haugen KL, Conti DV, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Pharoah PD, Song H, Kjaer SK, Hogdall E, et al. Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. Human Molecular Genetics. 20: 2263-72. PMID 21422097 DOI: 10.1093/Hmg/Ddr087 |
0.586 |
|
| 2011 |
Amankwah EK, Kelemen LE, Wang Q, Song H, Chenevix-Trench G, Beesley J, Webb PM, Pearce CL, Wu AH, Pike MC, Stram DO, Chang-Claude J, Wang-Gohrke S, et al. Prostate cancer susceptibility polymorphism rs2660753 is not associated with invasive ovarian cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 1028-31. PMID 21415361 DOI: 10.1158/1055-9965.Epi-11-0053 |
0.521 |
|
| 2011 |
Pharoah PD, Palmieri RT, Ramus SJ, Gayther SA, Andrulis IL, Anton-Culver H, Antonenkova N, Antoniou AC, Goldgar D, Beattie MS, Beckmann MW, Birrer MJ, Bogdanova N, Bolton KL, ... ... Pearce CL, et al. The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 3742-50. PMID 21385923 DOI: 10.1158/1078-0432.Ccr-10-3405 |
0.553 |
|
| 2011 |
Near AM, Wu AH, Templeman C, Van Den Berg DJ, Doherty JA, Rossing MA, Goode EL, Cunningham JM, Vierkant RA, Fridley BL, Chenevix-Trench G, Webb PM, Kjær SK, Hogdall E, Gayther SA, ... ... Pearce CL, et al. Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. Fertility and Sterility. 95: 40-5. PMID 20719308 DOI: 10.1016/J.Fertnstert.2010.06.059 |
0.375 |
|
| 2011 |
Notaridou M, Quaye L, Dafou D, Jones C, Song H, Høgdall E, Kjaer SK, Christensen L, Høgdall C, Blaakaer J, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Gentry-Maharaj A, ... ... Pearce CL, et al. Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer. International Journal of Cancer. Journal International Du Cancer. 128: 2063-74. PMID 20635389 DOI: 10.1002/Ijc.25554 |
0.484 |
|
| 2011 |
Berchuck A, Pharoah P, Ramus S, Gayther S, Palmieri R, Pearce C, Couch F, Antonio A, Goode E, Schildkraut J, Chenevix-Trench G, Sellers T, Risch H. Association of KRAS SNP rs61764370 with risk of invasive epithelial ovarian cancer: Implications for clinical testing Gynecologic Oncology. 121. DOI: 10.1016/J.Ygyno.2011.02.028 |
0.512 |
|
| 2011 |
Chandavarkar U, Campan M, Houshdaran S, Pearce C, Shen H, Widschwendter M, Berchuck A, Roman L, Laird P. DNA methylation markers associated with serous ovarian cancer subtypes Gynecologic Oncology. 120: S48. DOI: 10.1016/J.Ygyno.2010.12.117 |
0.444 |
|
| 2011 |
Berchuck A, Pike M, Schildkraut J, Pearce C. Common single-nucleotide polymorphisms in the BNC2, HOXD1 and MERIT40 regions contribute significantly to racial differences in ovarian cancer incidence Gynecologic Oncology. 120. DOI: 10.1016/J.Ygyno.2010.12.019 |
0.497 |
|
| 2010 |
Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY, Weidhaas J, Paik D, Van Den Berg DJ, Stram DO, Pearce CL, et al. Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nature Genetics. 42: 880-4. PMID 20852633 DOI: 10.1038/Ng.666 |
0.507 |
|
| 2010 |
Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK, Birrer MJ, Berchuck A, Schildkraut J, Tomlinson I, Kiemeney LA, ... ... Pearce CL, et al. A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nature Genetics. 42: 874-9. PMID 20852632 DOI: 10.1038/Ng.668 |
0.499 |
|
| 2010 |
Dafou D, Grun B, Sinclair J, Lawrenson K, Benjamin EC, Hogdall E, Kruger-Kjaer S, Christensen L, Sowter HM, Al-Attar A, Edmondson R, Darby S, Berchuck A, Laird PW, Pearce CL, et al. Microcell-mediated chromosome transfer identifies EPB41L3 as a functional suppressor of epithelial ovarian cancers. Neoplasia (New York, N.Y.). 12: 579-89. PMID 20651987 DOI: 10.1593/Neo.10340 |
0.356 |
|
| 2010 |
Johnatty SE, Beesley J, Chen X, Macgregor S, Duffy DL, Spurdle AB, deFazio A, Gava N, Webb PM, Rossing MA, Doherty JA, Goodman MT, Lurie G, Thompson PJ, Wilkens LR, ... ... Pearce CL, et al. Evaluation of candidate stromal epithelial cross-talk genes identifies association between risk of serous ovarian cancer and TERT, a cancer susceptibility "hot-spot". Plos Genetics. 6: e1001016. PMID 20628624 DOI: 10.1371/Journal.Pgen.1001016 |
0.564 |
|
| 2010 |
Kelemen LE, Goodman MT, McGuire V, Rossing MA, Webb PM, Köbel M, Anton-Culver H, Beesley J, Berchuck A, Brar S, Carney ME, Chang-Claude J, Chenevix-Trench G, ... ... Pearce CL, et al. Genetic variation in TYMS in the one-carbon transfer pathway is associated with ovarian carcinoma types in the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 1822-30. PMID 20570913 DOI: 10.1158/1055-9965.Epi-09-1317 |
0.465 |
|
| 2010 |
Phelan CM, Tsai YY, Goode EL, Vierkant RA, Fridley BL, Beesley J, Chen XQ, Webb PM, Chanock S, Cramer DW, Moysich K, Edwards RP, Chang-Claude J, Garcia-Closas M, Yang H, ... ... Pearce CL, et al. Polymorphism in the GALNT1 gene and epithelial ovarian cancer in non-Hispanic white women: the Ovarian Cancer Association Consortium. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 600-4. PMID 20142253 DOI: 10.1158/1055-9965.Epi-09-0861 |
0.581 |
|
| 2010 |
Doherty JA, Rossing MA, Cushing-Haugen KL, Chen C, Van Den Berg DJ, Wu AH, Pike MC, Ness RB, Moysich K, Chenevix-Trench G, Beesley J, Webb PM, Chang-Claude J, Wang-Gohrke S, Goodman MT, ... ... Pearce CL, et al. ESR1/SYNE1 polymorphism and invasive epithelial ovarian cancer risk: an Ovarian Cancer Association Consortium study. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 19: 245-50. PMID 20056644 DOI: 10.1158/1055-9965.Epi-09-0729 |
0.555 |
|
| 2009 |
Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R, Dörk T, Goode EL, Goodman MT, Schildkraut JM, Sellers T, ... ... Pearce CL, et al. A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nature Genetics. 41: 996-1000. PMID 19648919 DOI: 10.1038/Ng.424 |
0.541 |
|
| 2009 |
Canzian F, Kaaks R, Cox DG, Henderson KD, Henderson BE, Berg C, Bingham S, Boeing H, Buring J, Calle EE, Chanock S, Clavel-Chapelon F, Dossus L, Feigelson HS, Haiman CA, ... ... Pearce CL, et al. Genetic polymorphisms of the GNRH1 and GNRHR genes and risk of breast cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Bmc Cancer. 9: 257. PMID 19640273 DOI: 10.1186/1471-2407-9-257 |
0.483 |
|
| 2009 |
Widschwendter M, Apostolidou S, Jones AA, Fourkala EO, Arora R, Pearce CL, Frasco MA, Ayhan A, Zikan M, Cibula D, Iyibozkurt CA, Yavuz E, Hauser-Kronberger C, Dubeau L, Menon U, et al. HOXA methylation in normal endometrium from premenopausal women is associated with the presence of ovarian cancer: a proof of principle study. International Journal of Cancer. Journal International Du Cancer. 125: 2214-8. PMID 19621443 DOI: 10.1002/Ijc.24599 |
0.779 |
|
| 2009 |
Johnatty SE, Beesley J, Chen X, Spurdle AB, Defazio A, Webb PM, Goode EL, Rider DN, Vierkant RA, Anderson S, Wu AH, Pike M, Van Den Berg D, ... ... Pearce CL, et al. Polymorphisms in the FGF2 gene and risk of serous ovarian cancer: results from the ovarian cancer association consortium. Twin Research and Human Genetics : the Official Journal of the International Society For Twin Studies. 12: 269-75. PMID 19456219 DOI: 10.1375/Twin.12.3.269 |
0.572 |
|
| 2009 |
Song H, Ramus SJ, Kjaer SK, DiCioccio RA, Chenevix-Trench G, Pearce CL, Hogdall E, Whittemore AS, McGuire V, Hogdall C, Blaakaer J, Wu AH, Van Den Berg DJ, Stram DO, Menon U, et al. Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. Human Molecular Genetics. 18: 2297-304. PMID 19304784 DOI: 10.1093/Hmg/Ddp138 |
0.59 |
|
| 2009 |
Quaye L, Song H, Ramus SJ, Gentry-Maharaj A, Høgdall E, DiCioccio RA, McGuire V, Wu AH, Van Den Berg DJ, Pike MC, Wozniak E, Doherty JA, Rossing MA, Ness RB, Moysich KB, ... ... Pearce CL, et al. Tagging single-nucleotide polymorphisms in candidate oncogenes and susceptibility to ovarian cancer. British Journal of Cancer. 100: 993-1001. PMID 19240718 DOI: 10.1038/Sj.Bjc.6604947 |
0.516 |
|
| 2009 |
Taylor D, Pearce CL, Hovanessian-Larsen L, Downey S, Spicer DV, Bartow S, Pike MC, Wu AH, Hawes D. Progesterone and estrogen receptors in pregnant and premenopausal non-pregnant normal human breast. Breast Cancer Research and Treatment. 118: 161-8. PMID 19205874 DOI: 10.1007/S10549-009-0322-4 |
0.303 |
|
| 2009 |
Pearce CL, Chung K, Pike MC, Wu AH. Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin. Cancer. 115: 531-9. PMID 19127543 DOI: 10.1002/Cncr.23956 |
0.461 |
|
| 2009 |
Pearce CL, Near AM, Van Den Berg DJ, Ramus SJ, Gentry-Maharaj A, Menon U, Gayther SA, Anderson AR, Edlund CK, Wu AH, Chen X, Beesley J, Webb PM, Holt SK, Chen C, et al. Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium. British Journal of Cancer. 100: 412-20. PMID 19127255 DOI: 10.1038/Sj.Bjc.6604820 |
0.556 |
|
| 2009 |
Wu AH, Pearce CL, Tseng CC, Templeman C, Pike MC. Markers of inflammation and risk of ovarian cancer in Los Angeles County. International Journal of Cancer. Journal International Du Cancer. 124: 1409-15. PMID 19065661 DOI: 10.1002/Ijc.24091 |
0.527 |
|
| 2009 |
Pearce CL, Chung K, Pike MC, Wu AH. Increased risk of ovarian cancer associated with estrogen hormone therapy decreases with addition of progestogen Acta Ginecologica. 66: 69. |
0.394 |
|
| 2008 |
Palmieri RT, Wilson MA, Iversen ES, Clyde MA, Calingaert B, Moorman PG, Poole C, Anderson AR, Anderson S, Anton-Culver H, Beesley J, Hogdall E, Brewster W, Carney ME, Chen X, ... ... Pearce CL, et al. Polymorphism in the IL18 gene and epithelial ovarian cancer in non-Hispanic white women. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 17: 3567-72. PMID 19064572 DOI: 10.1158/1055-9965.Epi-08-0548 |
0.566 |
|
| 2008 |
Quaye L, Gayther SA, Ramus SJ, Di Cioccio RA, McGuire V, Hogdall E, Hogdall C, Blaakr J, Easton DF, Ponder BA, Jacobs I, Kjaer SK, Whittemore AS, Pearce CL, Pharoah PD, et al. The effects of common genetic variants in oncogenes on ovarian cancer survival. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 5833-9. PMID 18794094 DOI: 10.1158/1078-0432.Ccr-08-0819 |
0.485 |
|
| 2008 |
Berchuck A, Schildkraut JM, Pearce CL, Chenevix-Trench G, Pharoah PD. Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium. Advances in Experimental Medicine and Biology. 622: 53-67. PMID 18546618 DOI: 10.1007/978-0-387-68969-2_5 |
0.475 |
|
| 2008 |
Pearce CL, Van Den Berg DJ, Makridakis N, Reichardt JK, Ross RK, Pike MC, Kolonel LN, Henderson BE. No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned. Human Molecular Genetics. 17: 2456-61. PMID 18469342 DOI: 10.1093/Hmg/Ddn145 |
0.387 |
|
| 2008 |
Ramus SJ, Vierkant RA, Johnatty SE, Pike MC, Van Den Berg DJ, Wu AH, Pearce CL, Menon U, Gentry-Maharaj A, Gayther SA, Dicioccio RA, McGuire V, Whittemore AS, Song H, Easton DF, et al. Consortium analysis of 7 candidate SNPs for ovarian cancer. International Journal of Cancer. Journal International Du Cancer. 123: 380-8. PMID 18431743 DOI: 10.1002/Ijc.23448 |
0.532 |
|
| 2008 |
Pearce CL, Wu AH, Gayther SA, Bale AE, Beck PA, Beesley J, Chanock S, Cramer DW, DiCioccio R, Edwards R, Fredericksen ZS, Garcia-Closas M, Goode EL, Green AC, et al. Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the Ovarian Cancer Association Consortium pooled analysis. British Journal of Cancer. 98: 282-8. PMID 18219286 DOI: 10.1038/Sj.Bjc.6604170 |
0.612 |
|
| 2007 |
Pike MC, Wu AH, Spicer DV, Lee S, Pearce CL. Estrogens, progestins, and risk of breast cancer. Ernst Schering Foundation Symposium Proceedings. 127-50. PMID 18540571 |
0.308 |
|
| 2007 |
Gayther SA, Song H, Ramus SJ, Kjaer SK, Whittemore AS, Quaye L, Tyrer J, Shadforth D, Hogdall E, Hogdall C, Blaeker J, DiCioccio R, McGuire V, Webb PM, Beesley J, ... ... Pearce CL, et al. Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Research. 67: 3027-35. PMID 17409409 DOI: 10.1158/0008-5472.Can-06-3261 |
0.432 |
|
| 2006 |
Cox DG, Blanché H, Pearce CL, Calle EE, Colditz GA, Pike MC, Albanes D, Allen NE, Amiano P, Berglund G, Boeing H, Buring J, Burtt N, Canzian F, Chanock S, et al. A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3). Breast Cancer Research : Bcr. 8: R54. PMID 16987421 DOI: 10.1186/Bcr1602 |
0.441 |
|
| 2005 |
McKean-Cowdin R, Spencer Feigelson H, Xia LY, Pearce CL, Thomas DC, Stram DO, Henderson BE. BRCA1 variants in a family study of African-American and Latina women. Human Genetics. 116: 497-506. PMID 15726418 DOI: 10.1007/S00439-004-1240-5 |
0.391 |
|
| 2005 |
Pearce CL, Hirschhorn JN, Wu AH, Burtt NP, Stram DO, Young S, Kolonel LN, Henderson BE, Altshuler D, Pike MC. Clarifying the PROGINS allele association in ovarian and breast cancer risk: a haplotype-based analysis. Journal of the National Cancer Institute. 97: 51-9. PMID 15632380 DOI: 10.1093/Jnci/Dji007 |
0.551 |
|
| 2005 |
Freedman ML, Pearce CL, Penney KL, Hirschhorn JN, Kolonel LN, Henderson BE, Altshuler D. Systematic evaluation of genetic variation at the androgen receptor locus and risk of prostate cancer in a multiethnic cohort study. American Journal of Human Genetics. 76: 82-90. PMID 15570555 DOI: 10.1086/427224 |
0.472 |
|
| 2005 |
Sedlmeyer IL, Pearce CL, Trueman JA, Butler JL, Bersaglieri T, Read AP, Clayton PE, Kolonel LN, Henderson BE, Hirschhorn JN, Palmert MR. Determination of sequence variation and haplotype structure for the gonadotropin-releasing hormone (GnRH) and GnRH receptor genes: investigation of role in pubertal timing. The Journal of Clinical Endocrinology and Metabolism. 90: 1091-9. PMID 15546906 DOI: 10.1210/Jc.2004-0649 |
0.405 |
|
| 2005 |
Feigelson HS, Pearce CL, Diver WR, McKean-Cowdin R. CYP17 as a candidate gene for hormone-related cancers among women: A review of the evidence International Journal of Cancer Prevention. 2: 25-35. |
0.464 |
|
| 2004 |
Pike MC, Pearce CL, Wu AH. Prevention of cancers of the breast, endometrium and ovary Oncogene. 23: 6379-6391. PMID 15322512 DOI: 10.1038/Sj.Onc.1207899 |
0.469 |
|
| 2004 |
Pike MC, Pearce CL, Peters R, Cozen W, Wan P, Wu AH. Hormonal factors and the risk of invasive ovarian cancer: a population-based case-control study. Fertility and Sterility. 82: 186-95. PMID 15237010 DOI: 10.1016/J.Fertnstert.2004.03.013 |
0.493 |
|
| 2004 |
Pike MC, Pearce CL, Peters R, Cozen W, Wan P, Wu AH. Erratum: Hormonal factors and the risk of invasive ovarian cancer: A population-based case-control study (Fertility and Sterility (2004) 82:1 (186-195)) Fertility and Sterility. 82. DOI: 10.1016/J.Fertnstert.2004.07.923 |
0.476 |
|
| 2003 |
Paracchini S, Pearce CL, Kolonel LN, Altshuler D, Henderson BE, Tyler-Smith C. A Y chromosomal influence on prostate cancer risk: the multi-ethnic cohort study. Journal of Medical Genetics. 40: 815-9. PMID 14627670 DOI: 10.1136/Jmg.40.11.815 |
0.389 |
|
| 2003 |
Lohmueller KE, Pearce CL, Pike M, Lander ES, Hirschhorn JN. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nature Genetics. 33: 177-82. PMID 12524541 DOI: 10.1038/Ng1071 |
0.374 |
|
| 2000 |
Margiotti K, Sangiuolo F, De Luca A, Froio F, Pearce CL, Ricci-Barbini V, Micali F, Bonafe M, Franceschi C, Dallapiccola B, Novelli G, Reichardt JK. Evidence for an association between the SRD5A2 (type II steroid 5 alpha-reductase) locus and prostate cancer in Italian patients. Disease Markers. 16: 147-50. PMID 11381197 |
0.358 |
|
| 1999 |
Ross RK, Coetzee GA, Pearce CL, Reichardt JK, Bretsky P, Kolonel LN, Henderson BE, Lander E, Altshuler D, Daley G. Androgen metabolism and prostate cancer: establishing a model of genetic susceptibility. European Urology. 35: 355-61. PMID 10325489 DOI: 10.1159/000019909 |
0.374 |
|
| Show low-probability matches. |